Preterm Infants Physiological Parameters and Sleep-Wakefulness Status

Sponsor
Harran University (Other)
Overall Status
Completed
CT.gov ID
NCT05673213
Collaborator
(none)
60
1
2
5.8
10.3

Study Details

Study Description

Brief Summary

This research was carried out between December 2021 and May 2022 as a randomized controlled experimental design. In the study, between 28-35 weeks of gestation preterm infants were divided into two groups as the experimental group (n=30) and the control group (n=30). The block randomization method was used to ensure that the infants were similar in terms of both weeks and weight due to the large interval between the weeks and to ensure the balance between the groups. Infants in the control group were followed in the routine prone position of the neonatal intensive care unit, while infants in the experimental group were followed in the prone position with three-stair positioning pillows.

Condition or Disease Intervention/Treatment Phase
  • Other: Three-stair positioning pillows group
N/A

Detailed Description

This research was carried a randomized controlled experimental design. The sample size in the study was 1.08, type 1 error was 5%, and statistical power was 95%, according to the power analysis performed by taking into account the Breathing frequency values of the groups in the study called "Effectiveness of Hammock Positioning in Reducing Pain and Improving Sleep-Wakefulness State in Preterm Infants". It was calculated as a total of 48 participants, 24 in each group (Ribas et al., 2019). Considering the possibility of losses, 30 preterm infants with TSPP (experimental) and 30 preterm infants who were not used (control) were included and the infants were randomly assigned to the groups. The block randomization method was used to ensure that the infants were similar in terms of both weeks and weight due to the large interval between the weeks and to ensure the balance between the groups. Infants were divided into 2 groups as 28-31 week gestation and 32-35 week gestation. 30 infants were randomly distributed to each gestational week group as experimental and control groups through a program available at http://www.randomizer.org. Families were informed by the researcher about the method of the study through face-to-face interviews, written and verbal consents were obtained, and the information about preterm infants and their families was recorded in the "Information Form". The actigraphy measuring device was connected to the computer and the device was installed by entering the parameters such as the name and surname of the infant to be treated and the time interval in which the recordings would be made. Data were collected from a single hall in the NICU. The noise level of the intensive care unit (NICU) was measured with the Uni-T UT353 Mini Decibelmeter Device and the average noise level of the hall where the data were collected was between 50-55 dB. The infant was cared for, fed and treated by the primary nurse responsible for the infant between 08:30 and 08:55. No intervention was made to the preterm infant between 09:00-12:00 and the infant was allowed to rest. Between these hours, the oxygen saturation and heart rate of the preterm infants in both groups were counted by the researcher with a pulse oximeter device and recorded 18 times in 10 minutes. Sleep-wakefulness status was recorded by taking 15-second recordings with the Actigraphy measuring device. Preterm infants in the experimental group were followed in the prone position with three-stair positioning pillows and the infants in the control group were followed in the routine 15º head raised prone position between the hours of the research follow-up. The study followed the CONSORT guideline for reporting randomized controlled trials.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effects of Three-Stair Positioning Pillows Used for Preterm Infants on Physiological Parameters and Sleep-Wakefulness Status
Actual Study Start Date :
Dec 1, 2021
Actual Primary Completion Date :
Mar 15, 2022
Actual Study Completion Date :
May 28, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Routine 15º head raised prone position (control group)

The infant was cared for, fed and treated by the primary nurse responsible for the infant between 08:30 and 08:55. No intervention was made to the preterm infant between 09:00-12:00 and the infant was allowed to rest. Preterm infants were followed for 3 hours (09:00-12:00) with routine 15º head raised prone position. Between these hours, the oxygen saturation and heart rate of the preterm infants in were counted by the researcher with a pulse oximeter device and recorded 18 times in 10 minutes. Sleep-wakefulness status was recorded by taking 15-second recordings with the Actigraphy measuring device.

Experimental: Three-stair positioning pillows group

The infant was cared for, fed and treated by the primary nurse responsible for the infant between 08:30 and 08:55. No intervention was made to the preterm infant between 09:00-12:00 and the infant was allowed to rest. Preterm infants were followed for 3 hours (09:00-12:00) with three-stair positioning pillows. Between these hours, the oxygen saturation and heart rate of the preterm infants in were counted by the researcher with a pulse oximeter device and recorded 18 times in 10 minutes. Sleep-wakefulness status was recorded by taking 15-second recordings with the Actigraphy measuring device.

Other: Three-stair positioning pillows group
The infant was cared for, fed and treated by the primary nurse responsible for the infant between 08:30 and 08:55. No intervention was made to the preterm infant between 09:00-12:00 and the infant was allowed to rest. Preterm infants were followed for 3 hours (09:00-12:00) with three-stair positioning pillows. Between these hours, the oxygen saturation and heart rate of the preterm infants in were counted by the researcher with a pulse oximeter device and recorded 18 times in 10 minutes. Sleep-wakefulness status was recorded by taking 15-second recordings with the Actigraphy measuring device.

Outcome Measures

Primary Outcome Measures

  1. Sleep Status/minute [3 hours]

    Between 09:00-12:00

  2. Wakefulness Status/minute [3 hours]

    Measurements were made with an actigraphy device between 09:00 and 12:00.

  3. Physiological Parameters (oxygen saturation /%) [3 hours]

    Measurements were made with an actigraphy device between 09:00 and 12:00.

  4. Physiological Parameters (heart rate/minute ) [3 hours]

    Between 09:00-12:00

  5. Physiological Parameters (respiratory rate/minute ) [3 hours]

    Between 09:00-12:00

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Weeks to 35 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Only being diagnosed as preterm as a result of the examination performed by the physician,

  • Parent's willingness to participate in the research,

  • The infant is between 28-35 weeks of gestation,

  • Being in appropriate weight according to the week of gestation,

  • Having a history of intubation and being extubated.

Exclusion Criteria:
  • Surgical procedure has been applied,

  • Diagnosed with sepsis,

  • Congenital anomaly,

  • Taking analgesics 4 hours before, which may affect sleep,

  • Having hyperbilirubinemia,

  • Having hypoglycemia,

  • Presence of intracranial bleeding,

  • Receiving any oxygen support (nasal O2, incubator O2, etc.),

  • Intubated infants were not included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harran University Şanliurfa Turkey

Sponsors and Collaborators

  • Harran University

Investigators

  • Principal Investigator: Fatma BOZDAĞ, Lecturer, Harran University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fatma BOZDAG, Lecturer Doctor, Harran University
ClinicalTrials.gov Identifier:
NCT05673213
Other Study ID Numbers:
  • HRU-BOZDAG-002
First Posted:
Jan 6, 2023
Last Update Posted:
Jan 9, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 9, 2023